Comparative associations of oximetry patterns in Obstructive Sleep Apnea with incident cardiovascular disease.

"the matlab code utilized to calculate this metric is available ( https://github com/pdechazal/hypoxic-burden )."

"Disclosure Statement Financial disclosure: none. Non-financial or conflicts of interest: PAC and PdC have appointments to an endowed academic Chair at the University of Sydney that was created from ResMed funding. They receive no personal fees and this relationship is managed by an Oversight Committee of the University. PAC has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/ adviser to Zephyr Sleep Technologies, Signifier Medical Technologies, SomnoMed, and ResMed. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004). All other authors report no disclosures related to this work. Financial disclosure : none. Non-financial or conflicts of interest : PAC and PdC have appointments to an endowed academic Chair at the University of Sydney that was created from ResMed funding. They receive no personal fees and this relationship is managed by an Oversight Committee of the University. PAC has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/ adviser to Zephyr Sleep Technologies, Signifier Medical Technologies, SomnoMed, and ResMed. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004). All other authors report no disclosures related to this work."

"The authors gratefully acknowledge the Sleep Heart Health Study (SHHS) and the National Sleep Research Resource, supported by the National Heart, Lung, and Blood for making such data freely available for research. Disclosure Statement: Financial disclosure: none.: Non-financial or conflicts of interest: PAC and PdC have appointments to an endowed academic Chair at the University of Sydney that was created from ResMed funding. They receive no personal fees and this relationship is managed by an Oversight Committee of the University. PAC has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/ adviser to Zephyr Sleep Technologies, Signifier Medical Technologies, SomnoMed, and ResMed. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004). All other authors report no disclosures related to this work."